Related Articles
Imaging of HER2 may improve the outcome of external irradiation therapy for prostate cancer patients
Imaging agents for in vivo molecular profiling of disseminated prostate cancer - targeting EGFR receptors in prostate cancer: Comparison of cellular processing of [111In]-labeled affibody molecule ZEGFR:2377 and cetuximab
Imaging agents for in vivo molecular profiling of disseminated prostate cancer: Cellular processing of [111In]-labeled CHX-A''DTPA-trastuzumab and anti-HER2 ABY-025 Affibody in prostate cancer cell lines
Synthesis and pharmacological evaluation of novel epidermal growth factor receptor inhibitors against prostate tumor cells
Novel identification of the ETS-1 splice variants p42 and p27 in prostate cancer cell lines